https://doi.org/10.4081/btvb.2022.43
Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know
Submitted: 15 June 2022
Accepted: 1 August 2022
Published: 13 September 2022
Accepted: 1 August 2022
Abstract Views: 2119
PDF: 224
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The last report on Assisted Reproductive Technologies (ART) showed a steady increase in the annual number of treatment cycles worldwide. The most common techniques of autologous ART - in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) - require the use of exogenous gonadotropins with possible adverse effects [...].
Chambers GM, Dyer S, Zegers-Hochschild F, et al. International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology. Hum Reprod 2021;36:2921-34. doi: 10.1093/humrep/deab198. PMID: 34601605.
DOI: https://doi.org/10.1093/humrep/deab198
Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv 2018;2:3317-59. doi: 10.1182/bloodadvances.2018024802. PMID: 30482767; PMCID: PMC6258928.
DOI: https://doi.org/10.1182/bloodadvances.2018024802
Royal College of Obstetricians and Gynaecologists. The Management of Ovarian Hyperstimulation Syndrome. Green-top Guideline No. 5. London: RCOG; 2016.
Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 2002;8:559-77. doi: 10.1093/humupd/8.6.559. PMID: 12498425.
DOI: https://doi.org/10.1093/humupd/8.6.559
Piazza G. Oh Heavy Burden: Recognizing the Risk of Venous Thromboembolism in Women Undergoing Assisted Reproduction. Thromb Haemost 2018;118:2011-13. doi: 10.1055/s-0038-1676073. PMID: 30453350.
DOI: https://doi.org/10.1055/s-0038-1676073
Zohav E, Almog B, Cohen A, et al. A New Perspective on the Risk of Hypercoagulopathy in Ovarian Hyperstimulation Syndrome Using Thromboelastography. Reprod Sci 2017;24(12):1600-06. doi: 10.1177/1933719117697257. PMID: 28299993.
DOI: https://doi.org/10.1177/1933719117697257
Grandone E, Di Micco PP, Villani M, et al. Venous Thromboembolism in Women Undergoing Assisted Reproductive Technologies: Data from the RIETE Registry. Thromb Haemost 2018; 118:1962-68. doi: 10.1055/s-0038-1673402. PMID: 30296817.
DOI: https://doi.org/10.1055/s-0038-1673402
Sennström M, Rova K, Hellgren M, et al. Thromboembolism and in vitro fertilization - a systematic review. Acta Obstet Gynecol Scand 2017;96:1045-52. doi: 10.1111/aogs.13147. PMID: 28382684.
DOI: https://doi.org/10.1111/aogs.13147
Villani M, Favuzzi G, Totaro P, et al. Venous thromboembolism in assisted reproductive technologies: comparison between unsuccessful versus successful cycles in an Italian cohort. J Thromb Thrombolysis 2018;45:234-39. doi: 10.1007/s11239-017-1584-z. PMID: 29170876.
DOI: https://doi.org/10.1007/s11239-017-1584-z
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018;39:3165-41.
DOI: https://doi.org/10.1093/eurheartj/ehy478
Piazza G, Grandone E. Thrombophilia, Antithrombotic Therapy, and Recurrent Pregnancy Loss: A Call for Pragmatism in the Face of Unknowns. Semin Reprod Med 2021;39:167-69. doi: 10.1055/s-0041-1735628.
DOI: https://doi.org/10.1055/s-0041-1735628
How to Cite
Tiscia, G., & Grandone, E. (2022). Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know. Bleeding, Thrombosis and Vascular Biology, 1(2). https://doi.org/10.4081/btvb.2022.43
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Most read articles by the same author(s)
- Giovanni L. Tiscia, Donatella Colaizzo, Antonio De Laurenzo, Filomena Cappucci, Lucia Fischetti, Elena Chinni, Mario Mastroianno, Giovanni Favuzzi, Massimo Carella, Elvira Grandone, Thrombin generation assay in COVID-19 patients shows a hypocoagulable pattern , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 3 (2024)
- Francesco Marongiu, Elvira Grandone, Silvia Marongiu, Antonella Mameli, Doris Barcellona, Stroke in women: anticoagulation in a complicated puzzle , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 2 (2024)
- Roberto Mario Santi, Annamaria Fulghesu, Ezio Zanon, Erica De Candia, Elvira Grandone, Giancarlo Di Renzo, Claudia Succu, Valentina Tosto, Vincenzina Bruni, Paolo Gresele, Diagnosis and management of abnormal uterine bleeding in adolescence , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 1 (2024)
- Daniela Poli, Riccardo Tartaglia, Doris Barcellona , Paolo Bucciarelli , Antonio Ciampa, Elvira Grandone, Giuseppe Malcangi, Giuseppe Rescigno, Vincenzo Toschi, Sophie Testa, Alessandro Squizzato, Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 1 (2023)
Similar Articles
- Ottavia Borghese, Claudio Vincenzoni, Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial” , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 2 (2024)
- Guest Editors: Anna Falanga, Benjamin Brenner, Alok A. Khorana, Welcome to the 12th ICTHIC! , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. s1 (2024): 12th ICTHIC
- Luca Puccetti, Vincenzo Sammartano, Federico Caroni, Margherita Malchiodi, Paola Calzoni, Eleonora Franceschini, Lucrezia Galasso, Monica Bocchia, Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 3 (2022)
- Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol, The new era of anticoagulation: factor XI and XII inhibitors , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
- Lisa Pieri, Silvia Linari, Francesca Salvianti, Monica Attanasio, Giancarlo Castaman, Impaired platelet function in Hermansky-Pudlak syndrome associated with novel mutations in HPS3, HPS6 and HPS8 genes , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 3 (2024)
You may also start an advanced similarity search for this article.
